{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-102020","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2023-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.809480+00:00","generated_at":"2026-06-17T02:05:57.721033+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Director Kush Parmar resigns from Vor Biopharma board before 2023 annual meeting","bullets":["Kush Parmar, M.D., Ph.D., resigned effective immediately prior to the 2023 Annual Meeting.","Parmar was one of the longest-tenured directors, joining the Board in February 2019.","He previously served as Board chair (Jan-Jun 2021) and interim CEO (Feb-Aug 2019).","The resignation was not due to any disagreement with the Company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-102020","json":"https://secwatch.observer/filing/0001193125-23-102020.json","markdown":"https://secwatch.observer/filing/0001193125-23-102020.md","text":"https://secwatch.observer/filing/0001193125-23-102020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312523102020/0001193125-23-102020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312523102020/d493240d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:05:57.721033+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ada7438876","claim":"Kush Parmar, M.D., Ph.D. resigned as member of the Board of Directors at Vor Biopharma Inc..","evidence_excerpt":"On April 12, 2023, Kush Parmar, M.D., Ph.D., a member of the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”), delivered his notice of resignation to the Board, effective immediately prior to the 2023 Annual Meeting of Stockholders of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1817229/000119312523102020/0001193125-23-102020-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}